JHL Biotech raises $45.6 mln
JHL Biotech Inc. said Monday it closed a $45.6 million Series C round of funding. Existing investor Milestone Capital and new investors Sungent BioVenture and Liwick Investment Management participated. JHL is a biopharmaceutical company.
12 May 2015•2 mins read
